In partnership with Precision VH, this webinar is a virtual panel discussion where experts will describe and debate the contributions that Medical Affairs can make to early R&D (preclinical through Ph-IIb).
Topics can include:
- Anchoring R&D in a deep understanding of the disease and current approaches to treatment
- Understanding the science behind the treatment
- Identifying clinical, functional and economic endpoints relevant to value demonstration
- Capturing the voice of the patient, caregiver and healthcare professionals
- Augmenting investigator and site selection for clinical trials
- Strategies to engage key stakeholders including patients and prescribers
In this webinar, you will learn how to:
1. Identify and explore additional value drivers for Medical Affairs in biopharma organizations
2. Build alignment towards common goals and initiate appropriate collaboration between Medical Affairs and R&D
